Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2008 3
2009 2
2010 1
2011 1
2012 2
2013 1
2014 1
2015 2
2016 3
2017 2
2018 7
2019 4
2020 2
2021 2
2022 3
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

34 results

Results by year

Filters applied: . Clear all
Page 1
1,2-Diphenoxiethane salts as potent antiplasmodial agents.
Schiafino-Ortega S, Baglioni E, Pérez-Moreno G, Marco PR, Marco C, González-Pacanowska D, Ruiz-Pérez LM, Carrasco-Jiménez MP, López-Cara LC. Schiafino-Ortega S, et al. Bioorg Med Chem Lett. 2018 Aug 1;28(14):2485-2489. doi: 10.1016/j.bmcl.2018.05.060. Epub 2018 May 31. Bioorg Med Chem Lett. 2018. PMID: 29880399
Biological Evaluation of New Thienopyridinium and Thienopyrimidinium Derivatives as Human Choline Kinase Inhibitors.
Luque-Navarro PM, Mariotto E, Ballarotto M, Rubbini G, Aguilar-Troyano FJ, Fasiolo A, Torretta A, Parisini E, Macchiarulo A, Laso A, Marco C, Viola G, Carrasco-Jimenez MP, López-Cara LC. Luque-Navarro PM, et al. Pharmaceutics. 2022 Mar 27;14(4):715. doi: 10.3390/pharmaceutics14040715. Pharmaceutics. 2022. PMID: 35456549 Free PMC article.
New bioisosteric sulphur-containing choline kinase inhibitors with a tracked mode of action.
Luque-Navarro PM, Carrasco-Jiménez MP, Goracci L, Paredes JM, Espinar-Barranco L, Valverde-Pozo J, Torretta A, Parisini E, Mariotto E, Marchioro C, Laso A, Marco C, Viola G, Lanari D, López Cara LC. Luque-Navarro PM, et al. Eur J Med Chem. 2023 Jan 15;246:115003. doi: 10.1016/j.ejmech.2022.115003. Epub 2022 Dec 5. Eur J Med Chem. 2023. PMID: 36493617
New non-symmetrical choline kinase inhibitors.
Schiaffino-Ortega S, López-Cara LC, Ríos-Marco P, Carrasco-Jimenez MP, Gallo MA, Espinosa A, Marco C, Entrena A. Schiaffino-Ortega S, et al. Bioorg Med Chem. 2013 Nov 15;21(22):7146-54. doi: 10.1016/j.bmc.2013.09.003. Epub 2013 Sep 11. Bioorg Med Chem. 2013. PMID: 24080101
Lead optimization-hit expansion of new asymmetrical pyridinium/quinolinium compounds as choline kinase α1 inhibitors.
Rubbini G, Buades-Martín AB, Kimatrai-Salvador M, Entrena A, Gallo-Mezo MÁ, Ríos-Marco P, Marco C, Mattiuzzo E, Bortolozzi R, Mariotto E, Greco FA, Macchiarulo A, Carrasco-Jiménez MP, Viola G, López-Cara LC. Rubbini G, et al. Future Med Chem. 2018 Aug 1;10(15):1769-1786. doi: 10.4155/fmc-2018-0059. Epub 2018 Jul 25. Future Med Chem. 2018. PMID: 30043647
Anticancer Activity of the Choline Kinase Inhibitor PL48 Is Due to Selective Disruption of Choline Metabolism and Transport Systems in Cancer Cell Lines.
García-Molina P, Sola-Leyva A, Luque-Navarro PM, Laso A, Ríos-Marco P, Ríos A, Lanari D, Torretta A, Parisini E, López-Cara LC, Marco C, Carrasco-Jiménez MP. García-Molina P, et al. Among authors: lopez cara lc. Pharmaceutics. 2022 Feb 16;14(2):426. doi: 10.3390/pharmaceutics14020426. Pharmaceutics. 2022. PMID: 35214160 Free PMC article.
34 results